Ebooks
-
Adapting With Automation: A Guide For The Modern Lab
12/12/2023
The modern microbiology laboratory is starting to look very different from the laboratory of even 10 years ago. The work will be similar, yet technology will have advanced. Automation, in particular, is taking center stage.
-
Vaccine Maker's Toolkit: Strategies For Manufacturing And Supply Management
11/7/2023
This collection of insights highlights strategies and guidance to ensure reliable biomanufacturing capacity and supply chains for the delivery of health technologies, even during crisis conditions.
-
Scaling Cell and Gene Therapies
6/8/2023
Cell and gene therapy developers know that while there are opportunities to scale, there are also manufacturing gaps, capacity issues, and production timelines that require improvement to do so. And then, of course, there’s cost. Innovative systems such as automation, for example, may help developers to track materials through the production process, minimize labor requirements, and reduce the risk of human error. Because scale up and scale out are significant to everyone in the cell and gene sector, we’ve curated insightful editorial that addresses the most important aspects of scalability in the cell and gene therapy space.
-
Your Supply Chain On Inflation: An Outsourcing Analysis
12/30/2021
Outsourced Pharma Chief Editor Louis Garguilo has been an ahead-of-the-curve chronicler of inflation in the development and manufacturing supply chain. Based on interviews with biopharma professionals – from CEOs to frontline workers and consultants – he’s kept readers informed of rising outsourcing challenges, including the price for materials and services at CDMOs, and hard-to-find capacity as supply chains remain strained. Now we’ve collected four of Garguilo’s editorials with outsourcing professionals to help you understand what they and the entire industry is experiencing, what you can expect in 2022, and some steps you might be able to take to mitigate these market forces.
-
Improving Diversity In Clinical Trials
3/17/2021
The lack of diversity in clinical trials isn’t a new problem, but in 2020 this issue rose to the forefront of the industry as a spotlight was cast on drug development as a whole due to the COVID pandemic. In fact, a key milestone related to this topic came in November 2020 when the FDA issued its final guidance, Enhancing the Diversity of Clinical Trial Populations — Eligibility Criteria, Enrollment Practices, and Trial Designs. The experts in this ebook come from varying backgrounds, and as such, offer a myriad of recommendations relating to improving clinical trial enrollment of racial and ethnic minority groups.